PL2268308T3 - Szczepionka ochronna przeciwko lawsonia intracellularis - Google Patents

Szczepionka ochronna przeciwko lawsonia intracellularis

Info

Publication number
PL2268308T3
PL2268308T3 PL09753743T PL09753743T PL2268308T3 PL 2268308 T3 PL2268308 T3 PL 2268308T3 PL 09753743 T PL09753743 T PL 09753743T PL 09753743 T PL09753743 T PL 09753743T PL 2268308 T3 PL2268308 T3 PL 2268308T3
Authority
PL
Poland
Prior art keywords
vaccine
protection against
against lawsonia
lawsonia intracellulars
intracellulars
Prior art date
Application number
PL09753743T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2268308(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2268308T3 publication Critical patent/PL2268308T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL09753743T 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis PL2268308T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738 2008-11-06
PCT/EP2009/054516 WO2009144088A2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars
EP09753743.5A EP2268308B1 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars

Publications (1)

Publication Number Publication Date
PL2268308T3 true PL2268308T3 (pl) 2018-07-31

Family

ID=41212183

Family Applications (2)

Application Number Title Priority Date Filing Date
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis
PL09753743T PL2268308T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Country Status (13)

Country Link
US (3) US20110033496A1 (pl)
EP (3) EP2268308B1 (pl)
JP (2) JP6026106B2 (pl)
CN (1) CN102006883A (pl)
BR (2) BRPI0909769A2 (pl)
CA (1) CA2717969C (pl)
DK (2) DK3351267T3 (pl)
ES (1) ES2666671T3 (pl)
FR (1) FR21C1002I1 (pl)
HU (2) HUE038294T2 (pl)
PL (2) PL3351267T3 (pl)
TW (1) TWI551295B (pl)
WO (1) WO2009144088A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
WO2011054951A1 (en) 2009-11-09 2011-05-12 Intervet International B.V. Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
EP3076995B1 (en) 2013-12-03 2020-03-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
CA2931137C (en) 2013-12-03 2023-03-14 Intervet International B.V. Vaccine against porcine circo virus type 2
ES2695172T3 (es) * 2013-12-03 2019-01-02 Intervet Int Bv Vacuna porcina contra SRRP y Lawsonia intracellularis
WO2016124623A1 (en) 2015-02-04 2016-08-11 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
US10751405B2 (en) * 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
CN108135990A (zh) * 2015-10-22 2018-06-08 英特维特国际股份有限公司 用于保护mda阳性动物抵御由胞内劳森氏菌感染引起的病变的疫苗
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
CA3084042A1 (en) 2017-12-04 2019-06-13 Intervet International B.V. Vaccination with replicon particles and oil adjuvant
WO2019121513A1 (en) 2017-12-18 2019-06-27 Intervet International B.V. Swine influenza a virus vaccine
CN111757752A (zh) * 2018-02-28 2020-10-09 勃林格殷格翰动物保健有限公司 用于减少动物中的粪臭素和/或吲哚的方法
JP2023530133A (ja) 2020-06-19 2023-07-13 インターベット インターナショナル ベー． フェー． 遺伝子の特定の順序を有する核酸構築物を含むブタインフルエンザａウイルスワクチン
BR112022025735A2 (pt) 2020-06-19 2023-01-03 Intervet Int Bv Vacina de vírus da influenza a suína compreendendo um construto de ácido nucleico compreendendo a primeira, segunda e terceira sequências de ácido nucleico codificando antígenos de neuraminidase distintos do vírus
CN115697398A (zh) 2020-06-19 2023-02-03 英特维特国际股份有限公司 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗
CN115836082A (zh) 2020-06-19 2023-03-21 英特维特国际股份有限公司 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗
CN118139640A (zh) 2021-10-25 2024-06-04 英特维特国际股份有限公司 保护仔猪抵抗甲型猪流感病毒感染的疫苗
AU2022375120A1 (en) 2021-11-01 2024-04-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions
WO2024068637A1 (en) 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0382271T3 (da) 1989-02-04 1995-05-01 Akzo Nobel Nv Tocoler som adjuvanser i vacciner
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
ATE329031T1 (de) * 1995-11-30 2006-06-15 Agriculture Victoria Serv Pty Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
EP1177213A4 (en) * 1999-05-13 2002-08-28 Pfizer Prod Inc LAWSONIA DERIVATIVE GENE, POLYPEPTIDES, PEPTIDES AND HEMOLYSIN PROTEINS AND USES THEREOF
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
DK1586646T3 (da) 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine
UA87665C2 (ru) 2003-07-25 2009-08-10 Берингер Ингельхайм Ветмедика, Инк. Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
CA2554472A1 (en) 2004-01-22 2005-08-04 Intervet International B.V. Lawsonia intracellularis subunit vaccines
KR20070008625A (ko) * 2004-04-05 2007-01-17 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
CN102657855B (zh) * 2004-09-22 2015-12-09 葛兰素史密丝克莱恩生物有限公司 用于进行抗葡萄球菌接种的免疫原性组合物
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
ES2425228T3 (es) 2005-09-09 2013-10-14 Intervet International B.V. Vacuna contra el PCV-2
MX2008011247A (es) 2006-03-03 2008-09-11 Merial Ltd Vacuna de micoplasma hyopneumoniae.
NZ570805A (en) * 2006-03-30 2011-10-28 Glaxosmithkline Biolog Sa Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
KR101358517B1 (ko) 2006-04-10 2014-02-06 인터벳 인터내셔널 비.브이. 마이코플라즈마 ｐｒｒｓｖ에 대한 백신
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
MX2008015164A (es) 2006-05-30 2008-12-12 Intervet Int Bv Vacuna contra organismos de tipo rickettsia.
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig

Also Published As

Publication number Publication date
BRPI0909769A2 (pt) 2015-08-11
CA2717969A1 (en) 2009-12-03
EP3351267A1 (en) 2018-07-25
DK2268308T3 (en) 2018-05-22
WO2009144088A2 (en) 2009-12-03
US9198963B2 (en) 2015-12-01
HUE038294T2 (hu) 2018-10-29
CA2717969C (en) 2016-06-07
EP3351267B1 (en) 2020-08-05
JP2016026154A (ja) 2016-02-12
PL3351267T3 (pl) 2020-11-30
CN102006883A (zh) 2011-04-06
HUS2000047I1 (hu) 2020-12-28
JP6026106B2 (ja) 2016-11-16
US20110033496A1 (en) 2011-02-10
TW201002342A (en) 2010-01-16
BR122019000869B1 (pt) 2023-11-07
FR21C1002I1 (fr) 2021-03-05
EP2268308A2 (en) 2011-01-05
EP3708186A1 (en) 2020-09-16
ES2666671T3 (es) 2018-05-07
TWI551295B (zh) 2016-10-01
JP6138875B2 (ja) 2017-05-31
EP2268308B1 (en) 2018-03-14
US8597662B2 (en) 2013-12-03
DK3351267T3 (da) 2020-09-21
WO2009144088A3 (en) 2010-05-06
US20130302372A1 (en) 2013-11-14
US20130045228A1 (en) 2013-02-21
JP2011516600A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
HUS2000047I1 (hu) Vakcina Lawsonia intracellularis elleni védelemre
ZA201101481B (en) Vaccine
HRP20151124T1 (en) Vaccine
GB0700135D0 (en) Vaccine
GB0822001D0 (en) Vaccine
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
GB0816284D0 (en) Vaccine
SI2272146T1 (sl) Zaščitna naprava
ZA201103645B (en) Single-time vaccines
ZA201009141B (en) Protective devices
EP2252326A4 (en) VACCINE COMPOSITIONS
GB0816447D0 (en) Vaccine
GB0822028D0 (en) Protective suit
GB0801122D0 (en) Vaccine composition
GB0709373D0 (en) BCG-based anti-atheroma vaccine
HUE051465T2 (hu) Vakcina Lawsonia intracellularis elleni védelemre
GB0809781D0 (en) Vaccine
AP2010005295A0 (en) Vaccine
GB0820478D0 (en) Vaccine
GB0810914D0 (en) Vaccine
GB0810215D0 (en) Vaccine
GB0806461D0 (en) Anti-atheroma vaccine
GB0802108D0 (en) Vaccine
AU2008267307A1 (en) Vaccine